Glioblastoma
Glioblastoma is a fast-growing and aggressive type of brain cancer that arises from glial cells, often leading to severe symptoms and a challenging prognosis.
Glioblastoma Multiforme: Itraconazole with Radiotherapy and Temozolomide
We are studying whether adding Itraconazole to standard radiotherapy and temozolomide is safe for patients with newly diagnosed glioblastoma. Our goal is to find the best dose and understand its effects on survival and quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Have you had any previous treatment for brain tumors, such as chemotherapy or radiation?
- Are you currently pregnant or breastfeeding?
- Do you have serious heart problems, like congestive heart failure?
- Do you have serious liver disease, such as cirrhosis or hepatitis?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Assosept-S
Canadiol
Cladosol
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Otto Von Guericke Universitaet Magdeburg
University Clinic for Radiotherapy
Magdeburg, Germany
Sponsor: Otto Von Guericke Universitaet Magdeburg
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.